CLINICAL VALIDATION OF A SELECTIVE INHIBITOR OF MULTIDRUG AND TOXIN EXTRUSION PROTEIN, MATE1 (SLC47A1) IN HEALTHY VOLUNTEERS

被引：0
|
作者：
Hibma, J. E. [1 ]
Zur, A. A. [1 ]
Wittwer, M. B. [1 ]
Castro, R. A. [1 ]
Stocker, S. L. [1 ]
Morrissey, K. M. [1 ]
Goswami, S. [1 ]
Yee, S. [1 ]
Savic, R. M. [1 ]
Brett, C. M. [1 ]
Giacomini, K. M. [1 ]
机构：
[1] Univ Calif San Francisco, San Francisco, CA 94143 USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2014年 / 95卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S57 / S57
页数：1
相关论文
共 50 条
  • [31] Common variant in SLC47A1 encoding multidrug and toxin extrusion 1 transporter is associated with stronger effect of metformin on glycaemic control in type 2 diabetes
    Tkac, I.
    Javorsky, M.
    Klimcakova, L.
    Schroner, Z.
    Fabianova, M.
    Babjakova, E.
    Hermanova, H.
    DIABETOLOGIA, 2012, 55 : S130 - S130
  • [32] The first characterization of multidrug and toxin extrusion (MATE/SLC47) proteins in zebrafish (Danio rerio)
    Loncar, Jovica
    Popovic, Marta
    Krznar, Petra
    Zaja, Roko
    Smital, Tvrtko
    SCIENTIFIC REPORTS, 2016, 6
  • [33] The first characterization of multidrug and toxin extrusion (MATE/SLC47) proteins in zebrafish (Danio rerio)
    Jovica Lončar
    Marta Popović
    Petra Krznar
    Roko Zaja
    Tvrtko Smital
    Scientific Reports, 6
  • [34] Effects of genetic variants in SLC22A2 organic cation transporter 2 and SLC47A1 multidrug and toxin extrusion 1 transporter on cisplatin-induced adverse events
    Kazufumi Iwata
    Keiji Aizawa
    Saori Kamitsu
    Sachiko Jingami
    Eiko Fukunaga
    Minoru Yoshida
    Misato Yoshimura
    Akinobu Hamada
    Hideyuki Saito
    Clinical and Experimental Nephrology, 2012, 16 : 843 - 851
  • [35] Importance of the multidrug and toxin extrusion MATE/SLC47A family to pharmacokinetics, pharmacodynamics/toxicodynamics and pharmacogenomics
    Yonezawa, Atsushi
    Inui, Ken-ichi
    BRITISH JOURNAL OF PHARMACOLOGY, 2011, 164 (07) : 1817 - 1825
  • [36] Effects of genetic variants in SLC22A2 organic cation transporter 2 and SLC47A1 multidrug and toxin extrusion 1 transporter on cisplatin-induced adverse events
    Iwata, Kazufumi
    Aizawa, Keiji
    Kamitsu, Saori
    Jingami, Sachiko
    Fukunaga, Eiko
    Yoshida, Minoru
    Yoshimura, Misato
    Hamada, Akinobu
    Saito, Hideyuki
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2012, 16 (06) : 843 - 851
  • [37] Twelve Transmembrane Helices Form the Functional Core of Mammalian MATE1 (Multidrug and Toxin Extruder 1) Protein
    Zhang, Xiaohong
    He, Xiao
    Baker, Joseph
    Tama, Florence
    Chang, Geoffrey
    Wright, Stephen H.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (33) : 27971 - 27982
  • [38] ISCHEMIA-REPERFUSION-INDUCIBLE PROTEIN (IRIP) MODULATES THE FUNCTION OF ORGANIC CATION TRANSPORTER 1 (OCT1) AND MULTIDRUG AND TOXIN EXTRUSION 1 (MATE1) IN VITRO AND IN VIVO
    Li, Qing
    DRUG METABOLISM REVIEWS, 2012, 44 : 146 - 146
  • [39] Interaction of environmental contaminants with zebrafish (Danio rerio) multidrug and toxin extrusion protein 7 (Mate7/Slc47a7)
    Loncar, Jovica
    Smital, Tvrtko
    AQUATIC TOXICOLOGY, 2018, 205 : 193 - 203
  • [40] Lack of Influence of Substrate on Ligand Interaction with the Human Multidrug and Toxin Extruder, MATE1
    Martinez-Guerrero, Lucy J.
    Morales, Mark
    Ekins, Sean
    Wright, Stephen H.
    MOLECULAR PHARMACOLOGY, 2016, 90 (03) : 254 - 264
12345